IntroductionAlthough to date I have not found any references within the FDA warning letters directly relating to computerised systems and risk assessments within the pharmaceutical / biotechnology industry it is interesting to review inspection findings where risk assessments have been detailed.
In this post there is a review of two FDA warning letters which reference the use of documented risk
Wednesday, 13 April 2011
FDA Warning Letters - Risk Assessments
Posted on 11:13 by Unknown
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment